Paper of the Month - April, 2011

0 rating

Oral bisphosphonates and risk of cancer of oesophagus, stomach and colorectum: case-control analysis within a UK primary cohort

Green J, Czanner G, Reeves G et al.
Editor's note: Oral bisphosphonates are used to treat osteoporosis, which is now increasingly recognized as a problem in patients with conditions such as celiac disease and inflammatory bowel disease. Case reports have described an association between oral bisphosphonates and esophageal cancer. Using the UK General Practice Research Database (GPRD), the current authors sought to examine the possible association between the use of oral bisphosphonates and three different gastrointestinal (GI) cancers: esophageal, gastric, and colorectal.


READER POLL

Colorectal Cancer 3
Which imaging technique do you consider to be the most effective in the clinical staging of colorectal cancer?





Powered by NetPolls

WEB LINKS

SUBMIT AN ARTICLE